The inner leaflet of a typical mammalian plasma membrane contains 20-30% univalent PS (phosphatidylserine) and ~1% multivalent PtdIns(4,5)P 2 . Numerous proteins have clusters of basic (or basic/hydrophobic) residues that bind to these acidic lipids. The intracellular effector CaM (calmodulin) can reverse this binding on a wide variety of proteins, including MARCKS (myristoylated alanine-rich C kinase substrate), GAP43 (growth-associated protein 43, also known as neuromodulin), gravin, GRK5 (G-protein-coupled receptor kinase 5), the NMDA (N-methyl-D-aspartate) receptor and the ErbB family. We used the first principles of physics, incorporating atomic models and the Poisson-Boltzmann equation, to describe how the basic effector domain of MARCKS binds electrostatically to acidic lipids on the plasma membrane. The theoretical calculations show the basic cluster produces a local positive electrostatic potential that should laterally sequester PtdIns(4,5)P 2 , even when univalent acidic lipids are present at a physiologically relevant 100-fold excess; four independent experimental measurements confirm this prediction. Ca 2ϩ /CaM binds with high affinity (K d~1 0 nM) to this domain and releases the PtdIns(4,5)P 2 . MARCKS, a major PKC (protein kinase C) substrate, is present at concentrations comparable with those of PtdIns(4,5)P 2 (approx. 10 M) in many cell types. Thus MARCKS can act as a reversible PtdIns(4,5)P 2 buffer, binding PtdIns(4,5)P 2 in a quiescent cell, and releasing it locally when the intraBiochem. Soc. Symp. 72, [189][190][191][192][193][194][195][196][197][198] 
equipotential profile is not flat. Rather, the equipotential profile around each acidic lipid is approximately a hemisphere, with a value twice that predicted by Debye-Huckel theory: the factor of two is due to the image charge effect.
If we want to calculate the electrostatic binding energy of a basic peptide to a membrane from first principles, we need atomic level descriptions of not only the bilayer, but also the peptide. We place the peptide distance x from the bilayer, and calculate the potential everywhere in space. Once we know the potential and the location of each charge, we can calculate the energy of the peptide at that distance x. Repeating the calculation for different distances and orientations of the peptide allows us to calculate the average energy, and thus the concentration of the peptide as a function of distance. As discussed in detail elsewhere [6] [7] [8] , we then use the integral of the excess peptide concentration adjacent to the membrane, i.e. the 'Gibbs surface excess', to deduce net number of peptides 'bound' electrostatically.
Binding of peptides that mimic clusters of basic residues on proteins
The theoretical treatment makes very simple predictions for interaction of a basic peptide with a membrane containing univalent acidic lipid: the binding energy will increase (i) linearly with the number of basic residues in the peptide, (ii) linearly with the mole fraction of acidic lipid in the membrane, and (iii) as the salt concentration decreases. The experimental results agree satisfactorily with these predictions. For example, simple peptides with three, five and seven basic residues (e.g. Lys 3 , Lys 5 and Lys 7 ) bind with energies of 3, 5 and 7 kcal/mol (1 kcalϭ4.184 kJ) to 2:1 PC (phosphatidylcholine)/PS vesicles in 100 mM KCl [6] . Both centrifugation and FCS (fluorescence correlation spectroscopy) measurements show that the theory also predicts the membrane-binding behaviour of a more complicated basic peptide corresponding to the MARCKS (myristoylated alanine-rich C kinase substrate) effector region, MARCKS-(151-175), which has 13 basic and five hydrophobic residues: its molar partition coefficient increases exponentially from 10 2 to 10 8 (the binding energy increases linearly) as the mole fraction of PS in the membrane increases from 0 to 25% [9] . Finally, the electrostatic binding energy of simple basic peptides and small proteins increases as the salt concentration decreases, as predicted theoretically [6, 7] .
MARCKS as a paradigm for protein-membrane electrostatic interactions
Our studies with MARCKS and basic/hydrophobic peptides corresponding to its effector domain illustrate several general features of electrostatic membrane-protein interactions. The major PKC (protein kinase C) substrate in many different cell types, MARCKS is a 'natively unfolded' protein that binds to the plasma membrane through insertion of a myristate into the hydrocarbon core of the bilayer, and electrostatic interactions between a cluster of Interactions between proteins and lipids in the plasma membrane 191 basic amino acids in its effector domain and acidic lipids in the membrane [9, 10] . The basic cluster binds Ca 2ϩ /CaM (calmodulin) strongly, which produces translocation of the protein to the cytoplasm [10] . The structure of the effector domain-Ca 2ϩ /CaM complex is unusual because the complexed effector domain is not an amphipathic ␣-helix, but rather retains most of its elongated structure [11] . PKC phosphorylation of three serine residues in the effector domain also produces translocation of MARCKS to the cytoplasm, because it reduces the electrostatic interaction with the membrane, and the binding energy of myristate alone is not strong enough to anchor a protein to the plasma membrane. What does MARCKS do in a cell? Our working hypothesis is that MARCKS acts as a reversible PtdIns(4,5)P 2 buffer: the basic effector domain laterally sequesters PtdIns(4,5)P 2 through non-specific electrostatic interactions, then releases it when Ca 2ϩ /CaM binds to or PKC phosphorylates this domain [12] [13] [14] [15] .
Electrostatic calculations show that when a cluster of basic residues, such as the MARCKS-(151-175) peptide, binds to a PC/PS bilayer, it produces a local positive electrostatic potential (see Figure 4d of [12] , Figure 9F of [14] , Figure 12 of [15] , or [16] ) that acts as a basin of attraction for multivalent acidic lipids such as PtdIns(4,5)P 2 , which has a valence of approx. Ϫ4 at pH 7 [12] . Specifically, the potential experienced by PtdIns(4,5)P 2 far (Ͼ2 nm) from the peptide is approx. kT/eϭϪ25 mV and the potential experienced by PtdIns(4,5)P 2 close to the adsorbed cluster is ϩ25 mV. If we oversimplify and treat PtdIns(4,5)P 2 as a point charge with a valence of Ϫ4 that does not perturb the potential when it approaches the bound peptide, the Boltzmann relation predicts the potential of the positively charged adsorbed cluster will concentrate PtdIns(4,5)P 2 in the adjacent membrane region by approx. three orders of magnitude. Of course PtdIns(4,5)P 2 does have a finite size and does perturb the potential in its neighbourhood, but a more rigorous theoretical treatment based on the Poisson-Boltzmann relation and atomic models makes roughly the same prediction: the peptide should sequester PtdIns(4,5)P 2 even when PS is present at the 100-fold excess characteristic of biological membranes [16] .
Experimental evidence that MARCKS sequesters PtdIns(4,5)P 2 via electrostatic interactions
Our first indication that the MARCKS protein could sequester PtdIns(4,5)P 2 was admittedly indirect: we observed that it inhibited the activity of the enzyme PLC (phospholipase C), which catalyses hydrolysis of PtdIns(4,5)P 2 , on phospholipid membranes containing PC, PS and PtdIns(4,5)P 2 [8, 12] . The MARCKS-(151-175) peptide also inhibits PLC, and PKC phosphorylation or binding of Ca 2ϩ /CaM to the peptide reverses the inhibition [8, 12] . These data led us to explore the interactions between MARCKS and PtdIns(4,5)P 2 more deeply, and perform experiments that have provided more direct evidence that the cluster of basic residues on MARCKS does indeed sequester PtdIns(4,5)P 2 [15] .
We began by measuring binding of MARCKS-(151-175) to electrically neutral PC membranes. The effector domain peptide binds, albeit not very strongly, to PC bilayers, because its five phenylalanine residues penetrate into the hydrocarbon interior of the bilayer, as shown by magic angle spinning NMR and other experiments (see Figure 1 of [15] and references therein). When we incorporate 1% PtdIns(4,5)P 2 into the PC membrane, the binding of MARCKS-(151-175) increases by four orders of magnitude [17] ; specifically the molar partition coefficient, K, is ~10 2 M Ϫ1 for a PC vesicle and ~10 6 M Ϫ1 for a 99:1 PC/PtdIns(4,5)P 2 vesicle. (K is the reciprocal of the lipid concentration required to bind 50% of the peptide. 1/K may be regarded as an apparent dissociation constant of the peptide with a single lipid.) As expected for simple electrostatic interactions, the binding is independent of both the chemical nature of the basic residues [Lys 13 and Arg 13 peptides also bind with K=10 6 M Ϫ1 to 99:1 PC/PtdIns(4,5)P 2 vesicles] and the chemical nature of the PtdIns(4,5)P 2 {the peptide binds equally well to membranes formed from mixtures of PC with either PtdIns(3,4)P 2 or PtdIns(4,5)P 2 [13, 14] }.
When the peptide binds to a PC/PtdIns(4,5)P 2 membrane, three PtdIns(4,5)P 2 molecules diffuse towards the peptide and form an electrostatic binding site; this is why the forward rate constant depends on the mole fraction of PtdIns(4,5)P 2 in the membrane [14] . In contrast, peptide binding to a membrane formed from PC and a univalent acidic lipid, such as PS, does not perturb the lateral distribution of lipids in the membrane significantly; the forward rate constant remains diffusion limited as the mole fraction of PS in the membrane changes [18] . Biological membranes, of course, comprise numerous acidic lipids, and PtdIns(4,5)P 2 is present at much lower concentrations than univalent acidic lipids, such as PS. Can a basic peptide, or cluster of basic residues on a protein, laterally sequester PtdIns(4,5)P 2 via electrostatic interactions in membranes where PS is present at a 100-fold excess? Theoretical calculations predict that sequestration should occur [8, 16] . We measured the ability of MARCKS-(151-175) to sequester PtdIns(4,5)P 2 in PC/PS/PtdIns(4,5)P 2 membranes using four independent techniques -FRET (fluorescence resonance energy transfer), EPR, fluorescence self quenching, and PLC activity -and found significant sequestration using each technique [15] .
Binding due to non-specific electrostatic interactions differs from conventional stereospecific binding
We have focused on the role of non-specific electrostatic protein-membrane interactions, but it is important to recognize that many proteins have domains that bind specifically to phosphoinositides [19, 20] . The PH (pleckstrin homology) domain of PLC␦1, for example, forms hydrogen bonds with both the 4-and 5-phosphates in PtdIns(4,5)P 2 , holding it in a classical 'lock and key' complex. Comparison of the PtdIns(4,5)P 2 binding characteristics of this domain and the MARCKS basic effector region peptide show four important differences. First, stereospecific interactions require structure: the PLC␦1 PH domain has a known structure [19] , while MARCKS-(151-175) is unstructured, both in solution and when bound to a membrane [15] . Secondly, the ratio of protein/ligand in the complex is different: the PLC␦1 PH domain (and other similar phosphoinositide binding domains of known structure) binds one
Interactions between proteins and lipids in the plasma membrane 193
PtdIns(4,5)P 2 , while the MARCKS basic peptide, which has 13 positive residues, binds three PtdIns(4,5)P 2 molecules. Thirdly, the strength of interaction differs significantly: the PLC␦1 PH domain binds to 99:1 PC/PtdIns(4,5)P 2 vesicles with an affinity that is 100-fold weaker than that of MARCKS-(151-175). The high affinity of the unstructured peptide for the vesicle follows from its ability to combine with three PtdIns(4,5)P 2 molecules, whereas the PH domain binds to just one. Fourthly, the domains function differently: the well-established role of the PLC␦1 PH domain is to anchor the protein to the plasma membrane, enhancing the local concentration of PtdIns(4,5)P 2 substrate experienced by the catalytic domain [19] . We postulate that the function of the basic effector domain of MARCKS is to help control the free PtdIns(4,5)P 2 concentration in the membrane, laterally sequestering this signalling lipid PtdIns(4,5)P 2 , then releasing it locally in response to either PKC phosphorylation or binding of Ca 2ϩ /CaM [12] [13] [14] [15] .
Why controlling the free PtdIns(4,5)P 2 concentration in membranes is important
One of the enigmas of PtdIns(4,5)P 2 is that it plays an important role in such a wide variety of cell signalling processes; Figure 1 illustrates six of these functions.
Moving clockwise from the upper left of Figure 1 , we first note that PtdIns(4,5)P 2 produces three important second messengers. PLC-catalysed hydrolysis of PtdIns(4,5)P 2 yields the second messengers Ins(1,4,5)P 3 and DAG (diacylglycerol), and phosphorylation by PI3K (phosphoinositide 3-kinase) produces PtdIns(1,4,5)P 3 , which functions as a membrane anchor for several important proteins. Secondly, binding to PtdIns(4,5)P 2 targets some proteins with PH or other phosphoinositide-binding domains to the plasma membrane [19, 20] . As noted above, the PLC␦1 PH domain binds to PtdIns(4,5)P 2 very selectively. As this was the first PH domain to be understood in atomic detail, it was initially thought that most PH domains might also exhibit high selectivity. More recent detailed studies of several of the ~200 other PH domains reveals that the majority are much less selective for phosphoinositides [21] . Thirdly, several enzymes, e.g. PLD (phospholipase D), require PtdIns(4,5)P 2 for activation [22] . Fourthly, PtdIns(4,5)P 2 plays a role in maintaining the cytoskeleton, as shown by elegant laser tweezer experiments that demonstrate a dramatic release of this vital cellular structure in response to decreasing the level of PtdIns(4,5)P 2 in a cell [23] . Fifthly, there is good evidence that PtdIns(4,5)P 2 is involved in endocytosis [24] , and mounting evidence that suggests it may also be important in exocytosis [24] . Remarkably, Figure 1 does not cover all known PtdIns(4,5)P 2 functions; e.g. it activates several different classes of ion channels [25] [26] [27] .
The plethora of functions for this simple lipid molecule implies that its availability must be controlled very stringently. But how? One possibility is that kinases could produce PtdIns(4,5)P 2 locally on demand, as discussed by Anderson and colleagues [28] . Another possibility is that MARCKS, and other plasma membrane proteins, act as reversible PtdIns(4,5)P 2 buffers. The cell probably uses both mechanisms: both MARCKS and the kinases that synthesize PtdIns(4,5)P 2 are concentrated in the nascent phagosomes of macrophages and the ruffles of fibroblasts, two regions with high concentrations of PtdIns(4,5)P 2 .
MARCKS and other molecules may act as reversible PtdIns(4,5)P 2 buffers
We begin by defining the characteristics necessary for a putative PtdIns(4,5)P 2 buffer. Our biophysical studies suggest any protein with a cluster of four or more proximal basic residues that binds to the inner leaflet of the plasma membrane should be capable of laterally sequestering PtdIns(4,5)P 2 . The putative buffer must also be very abundant, since it must be present at a concentration comparable with that of PtdIns(4,5)P 2 (approx. 10 M) if it is to sequester a significant fraction of the PtdIns(4,5)P 2 in the plasma membrane. Only a few proteins are present at this concentration in cells. Finally, the sequestration must be reversible if the putative buffer functions to help control the level of PtdIns(4,5)P 2 . Caroni and colleagues discussed the cell biological studies suggesting that MARCKS, GAP43 (growth-associated protein 43, also known as neuromodulin) and CAP23 (cortical cytoskeleton-associated protein of 23 kDa) could function as buffers, or pipmodulins [29] . We recently began investigating GAP43, a peripheral membrane protein that is concentrated in the growth cones of developing neurons and has two palmitates (rather than a single myristate for MARCKS or CAP23) that anchor it strongly to the membrane. Our experiments with a peptide corresponding to the basic cluster on GAP43, GAP43-(30-57), indicate that the peptide binds both Ca 2ϩ /CaM and apoCaM with roughly the same affinity in 150 mM salt (U. Golebiewska, unpublished work), in agreement with an earlier report that the GAP43 protein binds apoCaM roughly as strongly as Ca 2ϩ /CaM [30] . Moreover, the GAP43-(30-57) peptide binds both Ca 2ϩ /CaM and apoCaM with sufficiently high affinity to compete with physiological (millimolar or greater) concentrations of 2:1 PC/PS membranes. These data suggest that both forms of CaM may bind to this region of GAP43 in a cell, blocking its interaction with PtdIns(4,5)P 2 . The basic cluster also contains a serine residue that is a target for PKC phosphoryla- tion; phosphorylation reduces the affinity of this region for CaM, allowing it to bind to PtdIns(4,5)P 2 in the membrane. If the basic region does bind to the membrane, it can laterally sequester PtdIns(4,5)P 2 : FRET experiments with GAP43-(30-57) produce results similar to those reported for MARCKS (U. Golebiewska, unpublished work). This leads us to speculate that GAP43 could be a PtdIns(4,5)P 2 buffer that functions in a complementary way to MARCKS; i.e. GAP43 sequesters PtdIns(4,5)P 2 in response to PKC phosphorylation (i.e. upon dissociation from CaM), acting as a reversible PtdIns(4,5)P 2 'sink', whereas MARCKS releases PtdIns(4,5)P 2 upon phosphorylation of its three serine residues (or binding to Ca 2ϩ /CaM), acting as a reversible PtdIns(4,5)P 2 'source'.
Other important proteins may also reversibly sequester PtdIns(4,5)P 2
Most plasma membrane proteins are not present at a sufficiently high concentration in the cell (approx. 10 M) to be capable of acting as reversible PtdIns(4,5)P 2 buffers. Nevertheless, the kinase GRK5 (G-protein-coupled receptor kinase 5) [31] , the scaffolding protein Gravin [32] , the NMDA (Nmethyl-D-aspartate) receptor [14] and the ErbB family of receptor tyrosine kinases all have clusters of basic/hydrophobic residues that probably bind to the inner leaflet of a plasma membrane. These basic clusters are capable of binding PtdIns(4,5)P 2 , and the available evidence suggests this binding will be reversed by Ca 2ϩ /CaM. For most of these proteins, the biological role of their basic/hydrophobic cluster has not yet been determined.
We have initiated a study of the ErbB family members, which all have a basic/hydrophobic region in the cytoplasmic juxtamembrane domain immediately adjacent to the transmembrane helix [33] . Peptides corresponding to these regions bind strongly to membranes containing acidic lipids; in each case, Ca 2ϩ /CaM can reverse this binding (S. McLaughlin, S.O. Smith, M. Hayman and D. Murray, unpublished work). Villalobo and co-workers have also shown that ErbB1 and ErbB2 are CaM-binding proteins [34, 35] . We have preliminary data that these basic clusters can laterally sequester PtdIns(4,5)P 2 based on measuring FRET between labels on PtdIns(4,5)P 2 and on a peptide corresponding to the basic/hydrophobic juxtamembrane cluster in ErbB1, ErbB1-(645-660). Activation of ErbB1 results in trans-autophosphorylation that produces a binding site for PLC␥ on the C-terminal portion of the ErbB molecule, suggesting that ErbB1 reversibly binds both PLC and its PtdIns(4,5)P 2 substrate. Moreover, the reversible (through Ca 2ϩ /CaM) binding of the juxtamembrane region to a bilayer leads to a new model for the activation of this important class of receptor tyrosine kinases (S. McLaughlin, S.O. Smith, M. Hayman and D. Murray, unpublished work). A new model is necessary because the ErbB family, unlike other receptor tyrosine kinases, does not require phosphorylation of tyrosine residues in the activation loop within the kinase domain for activation [36] . Thus we argue that biophysical studies of how clusters of basic/hydrophobic residues bind to membranes, laterally
